INFORMATION FOR
News
Discoveries & Impact highlights select scientific discoveries across the Department of Internal Medicine...
Genetics, gender, and even botched timing on the part of the immune response all appear important in the development of COVID-19. Akiko Iwasaki, PhD, is leading research to help us better predict who is likely to sail through a bout with COVID-19 and who may need targeted lifesaving care.
Immediately prior to the 38th annual J.P. Morgan Healthcare Conference, the YAA Shared Interest Groups department hosted alumni working in biotech and the life sciences at an evening reception in San Francisco at Orrick, Herrington & Sutcliffe.
Yale Cancer Center (YCC) is proud to announce several leadership appointments, including two new senior positions to help bolster YCC’s research mission in the coming years.
Yale's review of the ASCO 2019 Annual Meeting was held in Westbrook, CT on June 14.
Connecticut Magazine has named 72 Yale Cancer Center and Smilow Cancer Hospital physicians to its 2019 Best Doctors guide. Published in the magazine’s June issue, the Best Doctors list consists of 782 Connecticut physicians from 78 medical specialties.
Racial disparities in timely cancer treatment disappeared in states that expanded Medicaid under the Affordable Care Act (ACA), according to an analysis of over 30,000 health records led by researchers at Yale Cancer Center. The findings were presented at the American Society of Clinical Oncology (ASCO) 2019 annual meeting.
A new partnership with the National Cancer Center of China will provide opportunities for collaborative research, clinical trials and workforce training at the Yale School of Public Health, Yale Cancer Center and Yale Institute for Global Health.
Katerina Politi, PhD and Don Nguyen, PhD, members of the Signal Transduction Research Program at Yale Cancer Center (YCC), have received a 5-year, nearly $4 million National Cancer Institute (NCI) grant to support Lung Cancer research.
In a new study, Yale Cancer Center scientists have demonstrated a powerful method to analyze how tumor cells are altered as they metastasize to the brain.
Yale Cancer Center (YCC) and Smilow Cancer Hospital (SCH) are proud to announce a five-year grant awarded by The Frederick A. DeLuca Foundation to establish The DeLuca Center for Innovation in Hematology Research.
Results of a small clinical trial suggest that supplementing chemotherapy with high doses of vitamin D may benefit patients with metastatic colorectal cancer by delaying progression of the disease. The findings, by researchers from Yale Cancer Center and Dana-Farber Cancer Institute, are published in the Journal of the American Medical Association (JAMA).
Mandar Muzumdar, MD, assistant professor of genetics at the Yale Cancer Biology Institute, who has received the 2019 Cancer Research Early Career Award from the American Association for Cancer Research.
Former YCCI scholars, Christopher Pittenger, Eda Cengiz, Lucia Jilaveanu, Forrest Crawford, Tore Eid, and Shangqin Guo reflect on being a scholar.
Yale Cancer Center researchers have identified a potential therapy that combines two types of molecularly targeted drugs to produce a synergistic effect against head and neck cancer.
Yale Cancer Center is proud to announce the Basser BRCA Initiative grant. The $1 million, three-year gift was awarded to YCC by the Gray Foundation to advance the next generation of cancer therapies.